home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

3,776 rows where in_cev_map = 0 sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

surface_class 5

  • B_cargo 2,032
  • A_surface 708
  • unknown 560
  • A_assoc 303
  • A2_pm_peripheral 173

tier 2

  • Tier 1.5 2,348
  • Tier 1 1,428

has_structure 2

  • 1 2,098
  • 0 1,678

has_known_aptamer 2

  • 0 3,147
  • 1 629

has_cryoEM 2

  • 0 2,982
  • 1 794

in_cev_map 1

  • - · 3,776 ✖

has_activation_state_pdb_pair 1

  • 0 3,776
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P13569 CFTR Cystic fibrosis transmembrane conductance regulator Tier 1 0.824 1 A_surface 58 75.62 1 0     1 10 41148207, 31029337, 30595527, 22483890, 15657417 0 cystic fibrosis 0.9133535862571094
Q14654 KCNJ11 ATP-sensitive inward rectifier potassium channel 11 Tier 1 0.81 1 A_surface 9 83.81 1 0     0 0   0 type 2 diabetes mellitus 0.8651421397012851
P07949 RET Proto-oncogene tyrosine-protein kinase receptor Ret Tier 1 0.809 1 A_surface 34 78.81 1 0     1 83 41962371, 41744190, 41636718, 41526122, 41406741, 41171123, 41082837, 41060784, 41027166, 40932619, 40815127, 40711581, 40633058, 40602121, 40410423, 40285964, 40252505, 40222299, 39344894, 39288589, 39190775, 38953438, 38876068, 38852325, 38718747, 38604287, 38354543, 38282384, 38237282, 37851382, 37774402, 37757695, 37437453, 37245460, 36952259, 36315022, 35550937, 35420408, 34342436, 34132907, 34016094, 33513536, 33462661, 33119785, 33011620, 32760976, 32527800, 32212604, 32138930, 31897454 0 medullary thyroid gland carcinoma 0.8617460262224842
O95255 ABCC6 ATP-binding cassette sub-family C member 6 Tier 1.5 0.809 1 A_surface 4 80.94 0 0     0 0   0 Pseudoxanthoma elasticum 0.864631668818611
Q12809 KCNH2 Voltage-gated inwardly rectifying potassium channel KCNH2 Tier 1 0.806 1 A_surface 23 62.75 1 0     1 1 22617876 0 Romano-Ward syndrome 0.8549238933917284
P21439 ABCB4 Phosphatidylcholine translocator ABCB4 Tier 1.5 0.806 1 A_surface 4 83.25 1 0     0 0   0 progressive familial intrahepatic cholestasis type 3 0.851728159166962
P82251 SLC7A9 b(0,+)-type amino acid transporter 1 Tier 1 0.805 1 A_surface 4 85.44 1 0     0 0   0 cystinuria 0.8484952668941285
Q695T7 SLC6A19 Sodium-dependent neutral amino acid transporter B(0)AT1 Tier 1 0.804 1 A_surface 19 90.0 1 0     0 0   0 Hartnup disease 0.8464240093600148
P41180 CASR Extracellular calcium-sensing receptor Tier 1 0.804 1 A_surface 31 75.69 1 0     0 0   0 familial hypocalciuric hypercalcemia 1 0.8460848589627423
P31785 IL2RG Cytokine receptor common subunit gamma Tier 1.5 0.804 1 A_surface 14 75.5 1 0     1 2 30800133, 33869115 0 gamma chain deficiency 0.8469997000418428
Q9UM01 SLC7A7 Y+L amino acid transporter 1 Tier 1.5 0.804 1 A_surface 5 83.81 1 0     0 0   0 lysinuric protein intolerance 0.8450026270275782
P08100 RHO Rhodopsin Tier 1.5 0.804 1 A_surface 4 88.75 1 0     1 45 41963275, 41924874, 41636061, 40808302, 40642289, 40330320, 40045571, 39863313, 39788632, 38070612, 37191882, 36705086, 36696850, 36095194, 36049339, 35622174, 34709779, 34471566, 32696702, 32479610, 32319623, 32119944, 31737572, 31588238, 31535128, 29570714, 29281176, 28648779, 27893356, 25645980, 23757206, 23701883, 25033804, 22689339, 22302221, 22121695, 19766091, 19389625, 16419035, 12123800, 8743323, 7678562, 19188685, 18230760 0 retinitis pigmentosa 0.8481942240861982
P48029 SLC6A8 Sodium- and chloride-dependent creatine transporter 1 Tier 1.5 0.804 1 A_surface 6 84.62 1 0     0 0   0 creatine transporter deficiency 0.847268393806457
Q05586 GRIN1 Glutamate receptor ionotropic, NMDA 1 Tier 1 0.803 1 A_surface 84 82.88 1 0     0 0   0 neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant 0.8446685494288694
P07911 UMOD Uromodulin Tier 1 0.803 1 A_surface 10 82.94 1 0     1 4 37533140, 35446786 0 familial juvenile hyperuricemic nephropathy type 1 0.8446536377993564
O43526 KCNQ2 Potassium voltage-gated channel subfamily KQT member 2 Tier 1 0.803 1 A_surface 24 58.19 1 0     0 0   0 Benign familial neonatal seizures 0.8423358217314708
Q9UQD0 SCN8A Sodium channel protein type 8 subunit alpha Tier 1.5 0.803 1 A_surface 4 68.38 1 0     0 0   0 developmental and epileptic encephalopathy, 13 0.8437707419548253
P07333 CSF1R Macrophage colony-stimulating factor 1 receptor Tier 1 0.802 1 A_surface 26 77.81 0 0     1 1 29277631 0 leukoencephalopathy, diffuse hereditary, with spheroids 1 0.8391971566583056
Q9HBA0 TRPV4 Transient receptor potential cation channel subfamily V member 4 Tier 1 0.801 1 A_surface 19 71.62 1 0     0 0   0 metatropic dysplasia 0.8356240344517467
O95342 ABCB11 Bile salt export pump Tier 1.5 0.801 1 A_surface 8 83.12 1 0     1 1 36313979 0 progressive familial intrahepatic cholestasis type 2 0.8372060401943777
P78508 KCNJ10 ATP-sensitive inward rectifier potassium channel 10 Tier 1.5 0.801 1 A_surface 4 82.44 1 0     0 0   0 EAST syndrome 0.8357483559927158
P42262 GRIA2 Glutamate receptor 2 Tier 1 0.8 1 A_surface 16 84.94 0 0     1 4 28325839, 19417060, 17929944, 17024188 0 neurodevelopmental disorder with language impairment and behavioral abnormalities 0.8328652004757138
P16473 TSHR Thyrotropin receptor Tier 1 0.8 1 A_surface 9 74.0 1 0     1 6 41054857, 40997970, 40588369, 38650837 0 hypothyroidism due to TSH receptor mutations 0.8327127196409464
Q92736 RYR2 Ryanodine receptor 2 Tier 1 0.8 1 A_surface 26   1 0     1 1 24130701 0 catecholaminergic polymorphic ventricular tachycardia 1 0.8338648743498255
P30968 GNRHR Gonadotropin-releasing hormone receptor Tier 1.5 0.799 1 A_surface 1 84.19 0 0     0 0   0 hypogonadotropic hypogonadism 0.83100005285263
Q16281 CNGA3 Cyclic nucleotide-gated channel alpha-3 Tier 1.5 0.799 1 A_surface 10 74.44 1 0     0 0   0 achromatopsia 0.8315799021867489
P10912 GHR Growth hormone receptor Tier 1.5 0.799 1 A_surface 9 58.69 0 0     1 5 38811951, 38477735, 31603904 0 Laron syndrome 0.8304020079647765
P13866 SLC5A1 Sodium/glucose cotransporter 1 Tier 1.5 0.797 1 A_surface 4 84.38 1 0     0 0   0 glucose-galactose malabsorption 0.8220991027793896
Q04844 CHRNE Acetylcholine receptor subunit epsilon Tier 1.5 0.797 1 A_surface 13 80.69 1 0     0 0   0 Congenital myasthenic syndromes 0.8223287249629152
Q8IZF0 NALCN Sodium leak channel NALCN Tier 1 0.796 1 A_surface 5 76.69 1 0     0 0   0 congenital contractures of the limbs and face, hypotonia, and developmental delay 0.8198033442161259
P23942 PRPH2 Peripherin-2 Tier 1.5 0.796 1 A_surface 1 87.0 1 0     0 0   0 retinitis pigmentosa 0.8194208847382956
Q9BZV2 SLC19A3 Thiamine transporter 2 Tier 1.5 0.796 1 A_surface 19 81.56 1 0     0 0   0 biotin-responsive basal ganglia disease 0.8189646480334981
P41181 AQP2 Aquaporin-2 Tier 1 0.795 1 A_surface 7 91.75 1 0     0 0   0 diabetes insipidus, nephrogenic, autosomal 0.817870726313342
Q9ULV1 FZD4 Frizzled-4 Tier 1 0.795 1 A_surface 11 84.31 1 0     1 1 18673242 0 Familial exudative vitreoretinopathy 0.8152111103672746
Q13651 IL10RA Interleukin-10 receptor subunit alpha Tier 1 0.795 1 A_surface 7 62.0 1 0     1 2 25870409, 25558474 0 Autosomal recessive early-onset inflammatory bowel disease 0.8151052076044897
Q5JUK3 KCNT1 Potassium channel subfamily T member 1 Tier 1.5 0.795 1 A_surface 6 73.88 1 0     0 0   0 developmental and epileptic encephalopathy, 14 0.8165232785825526
Q01974 ROR2 Tyrosine-protein kinase transmembrane receptor ROR2 Tier 1 0.794 1 A_surface 6 68.31 0 0     1 2 41782379, 18673242 0 autosomal recessive Robinow syndrome 0.8145559265435566
Q9H222 ABCG5 ATP-binding cassette sub-family G member 5 Tier 1 0.793 1 A_surface 8 85.06 1 0     0 0   0 sitosterolemia 0.810555184820483
Q9UM73 ALK ALK tyrosine kinase receptor Tier 1 0.791 1 A_surface 79 68.19 0 0     1 6 40347134, 38604287, 32218299, 29205808, 24116381, 21281497 0 neuroblastoma 0.8016889264946979
Q9NQW8 CNGB3 Cyclic nucleotide-gated channel beta-3 Tier 1.5 0.791 1 A_surface 9 68.12 1 0     0 0   0 achromatopsia 0.8033348000666748
Q12866 MERTK Tyrosine-protein kinase Mer Tier 1 0.79 1 A_surface 42 72.25 0 0     0 0   0 retinitis pigmentosa 0.7985580877708576
Q4KMG0 CDON Cell adhesion molecule-related/down-regulated by oncogenes Tier 1 0.79 1 A_surface 3 62.03 0 0     1 3 36333824, 24629635, 18698484 0 holoprosencephaly 0.800378039564866
Q01718 MC2R Adrenocorticotropic hormone receptor Tier 1.5 0.79 1 A_surface 2 85.38 1 0     0 0   0 familial glucocorticoid deficiency 0.8001007686411645
Q9H1D0 TRPV6 Transient receptor potential cation channel subfamily V member 6 Tier 1 0.789 1 A_surface 24 80.56 1 0     0 0   0 hyperparathyroidism, transient neonatal 0.7964821997780153
P16871 IL7R Interleukin-7 receptor subunit alpha Tier 1 0.789 1 A_surface 8 67.44 0 0     0 0   0 immunodeficiency 104 0.7983119488718231
O43525 KCNQ3 Potassium voltage-gated channel subfamily KQT member 3 Tier 1.5 0.789 1 A_surface 1 56.72 0 0     0 0   0 Benign familial neonatal seizures 0.7961763561533409
P37023 ACVRL1 Activin receptor type-1-like Tier 1.5 0.789 1 A_surface 7 82.0 0 0     0 0   0 telangiectasia, hereditary hemorrhagic, type 2 0.7951167515831324
P15509 CSF2RA Granulocyte-macrophage colony-stimulating factor receptor subunit alpha Tier 1 0.788 1 A_surface 2 82.0 0 0     0 0   0 Congenital pulmonary alveolar proteinosis 0.7922592394513138
Q14028 CNGB1 Cyclic nucleotide-gated channel beta-1 Tier 1 0.788 1 A_surface 11 57.66 1 0     0 0   0 retinitis pigmentosa 0.7931901344765326
P16410 CTLA4 Cytotoxic T-lymphocyte protein 4 Tier 1.5 0.787 1 A_surface 22 80.12 0 0     1 26 41907643, 40972397, 40870970, 40811947, 40536609, 39417693, 38473398, 38158454, 36966395, 36831533, 36603108, 36015348, 33970170, 32929022, 32840510, 32280743, 32024070, 31405808, 28918052, 28082399, 26030229, 25565435, 24892807, 23460536, 23460531, 14612549 0 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency 0.7906408646569979

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 2225.263ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target